Three medications are currently FDA-approved for medication-assisted treatment of opioid addiction: methadone, buprenorphine (including formulations like Suboxone and Sublocade), and naltrexone (available as Vivitrol). Methadone and buprenorphine are opioid agonists that reduce cravings and withdrawal symptoms by activating opioid receptors in controlled ways, while naltrexone is an antagonist that blocks opioid effects entirely. These medications form the cornerstone of evidence-based opioid use disorder treatment and are often initiated during medically supervised detox.
Understanding FDA-Approved Medications for Opioid Use Disorder
The FDA has rigorously evaluated and approved specific medications to treat opioid dependence based on clinical trials demonstrating safety and efficacy. These approved medications for opioid use disorder work through distinct pharmacological mechanisms, but all share a common goal: stabilizing brain chemistry disrupted by chronic opioid exposure.
At Briarwood Detox Center, we incorporate these medication-assisted treatment options into our protocols at our Austin inpatient facility and our Houston and San Antonio outpatient programs. The choice of medication depends on withdrawal severity, opioid use history, medical factors, and patient preference.
Understanding how each medication works helps patients make informed decisions during the critical detox phase. Medication-assisted treatment isn’t a substitute for sobriety—it’s a medical tool that addresses the physiological component of opioid addiction while patients build recovery skills.
Methadone: The Longest-Established Opioid Treatment Medication
Methadone has been FDA-approved since 1972 for opioid addiction treatment. As a long-acting synthetic opioid agonist, it fully activates mu-opioid receptors in the brain, preventing withdrawal symptoms and reducing cravings without producing the euphoric rush associated with shorter-acting opioids like heroin or fentanyl.
Its pharmacological profile makes methadone particularly effective during acute withdrawal. The medication reaches steady-state levels slowly, providing 24 to 36 hours of coverage with a single daily dose. This extended duration stabilizes patients through the turbulent early days of detox.
Methadone administration is tightly regulated. It must be dispensed through certified opioid treatment programs under federal oversight. During medically supervised detox at our Austin facility, medical staff can administer methadone under protocols that prioritize safety and comfort throughout the withdrawal management process.
Buprenorphine: Partial Agonist Medication for Safer Treatment
Buprenorphine received FDA approval in 2002 and represents a significant advancement in opioid addiction treatment medications. As a partial opioid agonist, buprenorphine activates opioid receptors but produces a “ceiling effect”—beyond a certain dose, additional amounts don’t increase opioid effects. This pharmacological ceiling dramatically reduces overdose risk compared to full agonists.
The medication comes in several FDA-approved formulations. Suboxone combines buprenorphine with naloxone to deter misuse. Sublocade is a monthly injectable form that ensures consistent medication levels. Sublingual films and tablets allow flexible dosing during the detox and stabilization phases.
Buprenorphine can precipitate withdrawal if taken too soon after last opioid use, so timing matters. Our medical teams at Briarwood’s Austin, Houston, and San Antonio locations carefully assess withdrawal progression using objective scales before initiating buprenorphine, preventing this uncomfortable complication.
Mechanism of Action: How These Medications Work in the Brain
To understand what medications are FDA-approved for medication-assisted treatment of opioid addiction and why they work, you need to understand opioid receptor pharmacology. The human brain contains several types of opioid receptors, with mu-opioid receptors playing the primary role in both pain relief and addiction.
Chronic opioid use causes neuroadaptation—the brain reduces its natural endorphin production and increases receptor sensitivity. When opioids are suddenly removed, this imbalance creates the physical misery of withdrawal: muscle pain, nausea, anxiety, insomnia, and overwhelming cravings.
Methadone’s mechanism involves full receptor activation, essentially substituting a controlled, long-acting opioid for the problematic substance. Buprenorphine’s partial agonist action provides enough receptor stimulation to prevent withdrawal while blocking other opioids from binding. Both approaches give the brain time to restore neurochemical balance during detox.
Naltrexone: The Opioid Antagonist Approach to Treatment
Naltrexone takes an entirely different pharmacological approach. As a pure opioid antagonist, it occupies opioid receptors without activating them, effectively blocking any opioid from producing effects. The FDA approved oral naltrexone in 1984 and extended-release injectable naltrexone (Vivitrol) in 2010 specifically for opioid use disorder.
Unlike methadone and buprenorphine, naltrexone contains no opioid component and carries zero abuse potential. However, this creates a critical limitation: patients must complete full detox and be entirely opioid-free for 7 to 14 days before starting naltrexone. Taking it while opioids remain in the system triggers severe precipitated withdrawal.
Vivitrol’s monthly injection ensures medication adherence and provides consistent receptor blockade. For patients who successfully complete medically supervised detox at our Austin inpatient center, naltrexone can be an excellent option for preventing relapse during the transition to ongoing care.
Examples of Medication-Assisted Treatment in Detox Settings
MAT treatment for opioid addiction isn’t one-size-fits-all. Clinical application varies based on setting, patient needs, and withdrawal complexity. Here’s how medication-assisted treatment examples typically unfold during detox:
- Inpatient methadone stabilization: Patients withdrawing from high-dose fentanyl or heroin receive methadone doses adjusted daily based on withdrawal symptoms, heart rate, and blood pressure, with 24-hour medical monitoring at our Austin facility.
- Buprenorphine induction: Patients in moderate withdrawal begin low-dose buprenorphine, with doses increased over several days until withdrawal symptoms resolve and cravings diminish.
- Outpatient buprenorphine transition: Patients stabilized on buprenorphine during inpatient detox can transition to our Houston or San Antonio outpatient programs for continued monitoring and dose optimization.
- Naltrexone initiation post-detox: After completing opioid elimination during medically supervised detox, patients receive their first Vivitrol injection before discharge, establishing immediate relapse protection.
What Is the New Medicine for Opioid Addiction?
While methadone, buprenorphine, and naltrexone remain the FDA-approved core medications, newer formulations continue emerging. Sublocade (buprenorphine extended-release injection) received approval in 2017, offering monthly dosing that eliminates daily medication decisions. This extended-release buprenorphine formulation improves treatment retention in the vulnerable months following detox.
Research continues into novel opioid addiction treatment drugs targeting different neurobiological pathways. However, the three established FDA-approved medications remain the evidence-based standard. Any truly “new” medication must demonstrate safety and efficacy through rigorous clinical trials before earning FDA approval.
During detox at Briarwood, we focus on proven medications with decades of clinical data supporting their use. Innovation matters, but so does the reliability that comes from extensive real-world experience with these life-saving medications.
Which Medication Is Right During Detox?
Selecting among the opioid treatment medication list depends on multiple clinical factors. Medical history, concurrent substance use, liver function, pregnancy status, and previous medication experiences all influence the decision. Our physicians conduct comprehensive assessments before recommending a specific medication-assisted treatment approach.
Methadone may be preferred for patients with severe, long-term opioid dependence who need maximum symptom control. Buprenorphine offers flexibility for those seeking treatment in less restrictive settings or transitioning to outpatient care. Naltrexone works best for highly motivated patients who’ve completed detox and want absolute abstinence from all opioids.
No medication works in isolation. Successful withdrawal management combines FDA-approved medications with nursing support, symptom monitoring, hydration, nutrition, and psychological stabilization. This comprehensive approach defines quality detox care.
Medication-Assisted Treatment Across Briarwood’s Texas Locations
Briarwood Detox Center provides medication-assisted treatment for opioid addiction at our Texas facilities, tailored to each setting’s clinical capabilities. Our Austin inpatient program offers the highest level of medical supervision, ideal for complex withdrawal or patients requiring methadone stabilization with round-the-clock monitoring.
For patients with less severe withdrawal or those who’ve already achieved initial stabilization, our Houston and San Antonio outpatient detox programs provide buprenorphine management with regular medical check-ins. This model allows patients to begin recovery while maintaining work and family responsibilities.
Geography shouldn’t determine access to evidence-based care. Whether you’re in Austin, Houston, or San Antonio, Briarwood’s medical teams apply the same clinical protocols and commitment to safe, comfortable withdrawal management using FDA-approved medications.
Begin Medically Supported Opioid Detox in Texas
Understanding what medications are FDA-approved for medication-assisted treatment of opioid addiction is the first step. The next is reaching out for professional help. Briarwood Detox Center’s medical teams are ready to assess your situation and recommend the safest, most comfortable path through withdrawal at our Austin inpatient facility or Houston and San Antonio outpatient programs.
Ready to take the next step?
Briarwood Detox Center provides medically supervised drug & alcohol detox. Call (888) 857-0557 to speak with our team today.
